Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Lannett Co Inc (LCI)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (BATS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ fieldTitles[key] ]] [[ value ]] [[ value ]]
[[ ctrl.chartTitle ]]
Full Chart

Fundamentals

See More
  • Market Capitalization, $K 776,246
  • Shares Outstanding, K 37,230
  • Annual Sales, $ 542,490 K
  • Annual Income, $ 44,780 K
  • 36-Month Beta 2.71
  • Price/Sales 1.16
  • Price/Cash Flow N/A
  • Price/Book 1.40

Price Performance

See More
Period Period Low Period High Performance
1-Month
20.05 +2.74%
on 07/10/17
23.75 -13.26%
on 07/17/17
+0.10 (+0.49%)
since 06/27/17
3-Month
17.80 +15.73%
on 06/15/17
27.85 -26.03%
on 05/02/17
-5.35 (-20.62%)
since 04/27/17
52-Week
16.75 +22.99%
on 11/03/16
39.99 -48.49%
on 08/24/16
-10.70 (-34.19%)
since 07/27/16

Most Recent Stories

More News
5 Low Price-to-Book Stocks to Add to Your Kitty

When it comes to valuation metrics, though P/E and P/S are the first choices, the P/B ratio is also emerging as a convenient tool for identifying low-priced stocks that have high-growth prospects.

TOWR : 25.80 (+9.09%)
VLKAY : 31.6900 (-2.04%)
LCI : 20.60 (-1.20%)
CX : 9.59 (-2.74%)
CFG : 35.04 (-0.37%)
Corporate News Blog - Lannett Co. Receives Approval for Cyproheptadine Hydrochloride Syrup

LONDON, UK / ACCESSWIRE / July 17, 2017 / Pro-Trader Daily takes a look at the latest corporate events and news making the headlines for Lannett Co., Inc. (NYSE: LCI), following which we have published...

LCI : 20.60 (-1.20%)
MRK : 63.69 (+3.06%)
Lannett Appoints Samuel H. Israel As General Counsel

Lannett Company, Inc. (NYSE: LCI) today announced the appointment of Samuel H. Israel as vice president, chief legal officer and general counsel.

LCI : 20.60 (-1.20%)
Shares of Depomed Inc Rank the Highest in Terms of Relative Performance in the Pharmaceuticals Industry (DEPO, NEOS, HZNP, TTPH, LCI)

Here are the top 5 stocks in the Pharmaceuticals industry ranked by performance. We compiled the trading activity from yesterday and then analyzed the industry looking for stocks that were outperforming....

LCI : 20.60 (-1.20%)
HZNP : 12.66 (-4.24%)
DEPO : 10.44 (-4.31%)
NEOS : 6.50 (-3.70%)
TTPH : 6.96 (-11.68%)
Lannett wins US FDA approval for additional dosage strengths of Hydrocodone Bitartrate and Acetaminophen Tablets USP

Pharmaceutical products company Lannett Company Inc (NYSE:LCI) disclosed on Monday the receipt of approval from the US Food and Drug Administration (FDA) of its Abbreviated New Drug Application (ANDA)...

LCI : 20.60 (-1.20%)
AGN : 254.16 (-0.78%)
Lannett Receives Approval For Additional Dosage Strengths Of Hydrocodone Bitartrate And Acetaminophen Tablets USP

Lannett Company, Inc. (NYSE: LCI) today announced that it received approval from the U.S. Food and Drug Administration (FDA) of its Abbreviated New Drug Application (ANDA) for Hydrocodone Bitartrate and...

LCI : 20.60 (-1.20%)
AGN : 254.16 (-0.78%)
Lannett wins US FDA approval for Hydrocodone Bitartrate and Acetaminophen Tablets USP in 5 mg/300 mg, 7.5 mg/300 mg and 10 mg/300 mg

Pharmaceutical company Lannett Company Inc (NYSE:LCI) reported on Thursday the receipt of approval from the US Food and Drug Administration (FDA) of its Abbreviated New Drug Application (ANDA) for Hydrocodone...

LCI : 20.60 (-1.20%)
Lannett Receives Approval For Hydrocodone Bitartrate and Acetaminophen Tablets USP, 5 mg/300 mg, 7.5 mg/300 mg And 10 mg/300 mg

Lannett Company, Inc. (NYSE: LCI) today announced that it received approval from the U.S. Food and Drug Administration (FDA) of its Abbreviated New Drug Application (ANDA) for Hydrocodone Bitartrate and...

LCI : 20.60 (-1.20%)
Featured Company News - Lannett Announces Approval for Amantadine Hydrochloride Capsules USP, 100 mg; Set to Launch Before the Flu Season

LONDON, UK / ACCESSWIRE / June 19, 2017 / Pro-Trader Daily takes a look at the latest corporate events and news making the headlines for Lannett Co., Inc. (NYSE: LCI). The Company announced on June 16,...

LCI : 20.60 (-1.20%)
Lannett wins US FDA approval for Amantadine Hydrochloride Capsules USP, 100 mg

Generic pharmaceutical company Lannett Company Inc (NYSE:LCI) reported on Friday the receipt of approval for its Abbreviated New Drug Application (ANDA) for Amantadine Hydrochloride Capsules USP, 100 mg...

LCI : 20.60 (-1.20%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 16% Sell with a Weakening short term outlook on maintaining the current direction.

Longer term, the trend strength is Weak. Long term indicators fully support a continuation of the trend.

The market is approaching oversold territory. Be watchful of a trend reversal.

See More

Business Summary

Lannett, Inc. manufactures and distributes pharmaceutical products sold under generic names and historically has manufactured and distributed pharmaceutical products sold under its trade or brand names. In addition, the Company contract manufactures and private labels pharmaceutical products for other...

See More

Support & Resistance

2nd Resistance Point 21.15
1st Resistance Point 21.00
Last Price 20.60
1st Support Level 20.65
2nd Support Level 20.45

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.